Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000221026 | SCV000272321 | uncertain significance | not specified | 2015-05-26 | criteria provided, single submitter | clinical testing | The c.1187-10G>C in PRDM16 has not been previously reported in individuals with cardiomyopathy, but has been identified in 15/65236 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs2015 17837). This variant is located in the 3' splice region. Computational tools do not predict altered splicing, though this information is not predictive enough t o rule out pathogenicity. In summary, the clinical significance of the c.1187-10 G>C variant is uncertain. |
Gene |
RCV001707559 | SCV000732642 | likely benign | not provided | 2020-01-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000651672 | SCV000773526 | likely benign | Left ventricular noncompaction 8 | 2025-01-07 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000221026 | SCV005395243 | benign | not specified | 2024-09-22 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000221026 | SCV001921604 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001707559 | SCV001953785 | likely benign | not provided | no assertion criteria provided | clinical testing |